glp 1 drugs covered by medicaid The evolving landscape of anti-obesity medication coverage in Pennsylvania Medicaid stopped covering GLP-1s

Most long-term studies show that sustained weight loss is associated with improved mental health outcomes, including reduced anxiety

Numerators latest syndicated research aims to provide a more in-depth understanding of past, current and future users to paint a more complete picture of the GLP-1 lifecycle and the stickiness of behavioral shifts

For instance, in one observational study, a larger reduction in added sugars and a greater increase in dietary protein were seen among participants receiving GLP-1s plus dietary counseling compared to GLP-1s alone [147]

Support continues via messaging, and medication is aligned to coverage or flat-rate plan